Probi CEO joins Board of Directors

22 July 2021 Probi CEO joins Board of Directors Blis Technologies Limited (NZX:BLT) advises the appointment of Tom Ronnlund as a director of the company with effect from 22 July 2021. Mr Ronnlund is currently the CEO of Probi AB, a world leading Swedish listed biotechnology company. Founded in Lund in 1991, Probi today is one of the largest and leading global probiotics companies. Before joining Probi AB in January 2019, Mr Ronnlund served as CEO of Navamedic ASA, a listed Norwegian pharma and medtech company. Mr Ronnlund has more than 20 years experience working in the healthcare industry, and has held several positions in sales, marketing and general management at IQVIA and in international biopharmaceutical companies such as Bristol-Myers Squibb and Eli Lilly. The board has determined that Mr Ronnlund is not an independent director due to his role as CEO of Probi AB, which is a substantial product holder of Blis Technologies. Mr Ronnlund will formally offer himself for re-election as director at the 2022 shareholders' meeting. Chairman Tony Offen said "We are delighted that Tom is joining the board. Tom will bring valuable capability and experience to the board with his background of international business development through his leadership roles held across healthcare, pharma and currently as CEO of Probi, a world leading probiotics company" Ends For further information, please contact: Geoff Plunket Chairman +64 21 229 8886 About Blis Technologies Ltd Delivering proven health benefits through evidence-based, advanced probiotics Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS(R) products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz. Website: www.unconditionalskin.com Instagram: @unconditionalskin #BLISQ24 #USC Facebook: @unconditionalskin About Probi Probi(R) is a global company focused exclusively on researching, manufacturing, and delivering probiotics for supplements and functional food. We are experts at managing stable, live bacteria from R&D through every stage of the manufacturing process and are dedicated to making the health-enhancing benefits of probiotics available to people everywhere. Our health concepts, formulations, and formats are supported by robust clinical documentation. Since our founding in 1991 at Sweden's Lund University, Probi has expanded its operations to more than 40 markets. We hold more than 400 patents globally. Read more at www.probi.com. Probi(R) is a registered trademark of Probi AB. End CA:00376059 For:BLT Type:ADMIN Time:2021-07-22 12:07:31